$28MIndia’s exports in 2025
148countries bought from India in 2025
3,434tonnes shipped in 2025
under 1%of 3004 exports
India’s exports, year by year
US$, calendar years, all destinations combined. Source: UN Comtrade (India’s own reports).
Biggest buyers, 2025
- Togo
- United Arab Emirates
- USA
- Philippines
- Poland
- Mauritius
- Jamaica
- Chile
- Belgium
- Kenya
Ranked by value. Country-by-country figures are not shown.
Indian tariff lines (8-digit) and GST
| ITC-HS code | Description | GST |
|---|---|---|
| 3004.49.10 | Atropin and salts thereof | 5% |
| 3004.49.20 | Caffein and salts thereof | 5% |
| 3004.49.30 | Codeine and derivatives, with or without ephidrine | 5% |
| 3004.49.40 | Ergot preparations, ergotamine and salts thereof | 5% |
| 3004.49.50 | Papavarine hydrochloride | 5% |
| 3004.49.60 | Bromohexin and solbutamol | 5% |
| 3004.49.70 | Theiphylline of vitamins | 5% |
| 3004.49.90 | Other | 5% |
GST on supply within India, as of 1 May 2026. Where two rates are shown, the rate depends on a condition in the GST notification: open the code for the exact rule. Exports are zero-rated supplies.
Other codes in 3004
3004.90Medicaments — other types$20B in 20253004.20Medicaments — containing other antibiotics$1.2B in 20253004.10Medicaments — containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins$758M in 20253004.50Medicaments — other medicaments containing vitamins or other products of heading 2936$307M in 20253004.39Medicaments — other types$261M in 20253004.60Medicaments — other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter$185M in 20253004.32Medicaments — containing corticosteroid hormones,their derivatives or structural analogues$166M in 20253004.31Medicaments — containing insulin$136M in 20253004.41Medicaments — containing alkaloids or derivatives thereof but not containing hormones, other products of heading 2…$750K in 20253004.42Medicaments — containing alkaloids or derivatives thereof but not containing hormones, other products of heading 2…$150K in 20253004.43Medicaments — containing alkaloids or derivatives thereof but not containing hormones, other products of heading 2…$120K in 2025